CorVent Medical Appoints Richard S. Walsh as Chief Executive Officer

NEW YORK CITY, NY, August 4, 2020 – CorVent Medical, a Coridea portfolio company focused on developing smart, versatile, lifesaving ventilators for critical care, announced today the appointment of Richard S. Walsh to Chief Executive Officer (CEO). Mr. Walsh comes with almost three decades in the industry, both with start-ups and large, global organizations, and brings a wealth of medtech and senior leadership experience. He joins CorVent as the team prepares to commercialize its RESPOND-19™ ventilator and position the company as an innovator in reliable, lifesaving ventilators that efficiently address overflow ventilation needs.